Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: A self-controlled case series

BMJ Open

Volumn 6, Issue 1, 2016, Pages

  Cohet, Catherine ^a   Haguinet, François ^a   Santos, Gaël Dos ^b   Webb, Dave ^c   Logie, John ^c   Ferreira, Germano L C ^a   Rosillon, Dominique ^a   Shinde, Vivek ^a  

^a GSK   (Belgium)

^b Business and Decision Life Sciences   (Belgium)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; BACTERIAL INFECTION; CARDIAC GRAFT REJECTION; CASE STUDY; CHILD; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; INFANT; INFLUENZA A VIRUS (H1N1); INFLUENZA VACCINATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; SEASONAL INFLUENZA; UNITED KINGDOM; VIRUS INFECTION; ADVERSE EFFECTS; INFLUENZA, HUMAN; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME FACTOR; VACCINATION;

GRAFT REJECTION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; UNITED KINGDOM; VACCINATION;

EID: 84960335668     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-009264     Document Type: Article

References (59)

1. Avery RK. Influenza vaccines in the setting of solid-organ transplantation: are they safe? Curr Opin Infect Dis 2012;25:464-8.
2. Cordero E, Manuel O. Influenza vaccination in solid-organ transplant recipients. Curr Opin Organ Transplant 2012;17:601-8.
3. Kumar D, Blumberg EA, Danziger-Isakov L, et al. Influenza vaccination in the organ transplant recipient: review and summary recommendations. Am J Transplant 2011;11:2020-30.
4. Zbinden D, Manuel O. Influenza vaccination in immunocompromised patients: efficacy and safety. Immunotherapy 2014;6:131-9.
5. Brakemeier S, Schweiger B, Lachmann N, et al. Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix®) in renal transplant recipients. Nephrol Dial Transplant 2012;27:423-8.
6. Katerinis I, Hadaya K, Duquesnoy R, et al. De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients. Am J Transplant 2011;11:1727-33.
7. Schaffer SA, Husain S, Delgado DH, et al. Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients. Am J Transplant 2011;11:2751-4.
8. Danziger-Isakov L, Cherkassky L, Siegel H, et al. Effects of influenza immunization on humoral and cellular alloreactivity in humans. Transplantation 2010;89:838-44.
9. Burbach G, Bienzle U, Stark K, et al. Influenza vaccination in liver transplant recipients. Transplantation 1999;67:753-5.
10. Candon S, Thervet E, Lebon P, et al. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant 2009;9:2346-54.
11. Hurst FP, Lee JJ, Jindal RM, et al. Outcomes associated with influenza vaccination in the first year after kidney transplantation. Clin J Am Soc Nephrol 2011;6:1192-7.
12. Lawal A, Basler C, Branch A, et al. Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant 2004;4:1805-9.
13. Magnani G, Falchetti E, Pollini G, et al. Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study. J Heart Lung Transplant 2005;24:588-92.
14. Scharpe J, Evenepoel P, Maes B, et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008;8:332-7.
15. Altamirano-Diaz L, West L, Humar A, et al. Early post-transplant vaccination with pandemic influenza A/H1N1 vaccine in pediatric heart transplant recipients. Pediatr Transplant 2011;15:172-5.
16. Broeders NE, Hombrouck A, Lemy A, et al. Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. Clin J Am Soc Nephrol 2011;6:2573-8.
17. Crespo M, Collado S, Mir M, et al. Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol 2011;6:2208-14.
18. Felldin M, Studahl M, Svennerholm B, et al. The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients. Transpl Int 2012;25:166-71.
19. Goldschmidt I, Pfister ED, Becker M, et al. Acceptance and adverse events of the 2009 H1N1 vaccination in immunosuppressed pediatric liver transplant recipients. J Pediatr 2011;158:329-33.
20. Meyer S, Adam M, Schweiger B, et al. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Transplantation 2011;91:1031-5.
21. Salles MJC, Sens YAS, Malafronte P, et al. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients. Transpl Infect Dis 2012;14:564-74.
22. Schuurmans MM, Tini GM, Dalar L, et al. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort. J Heart Lung Transplant 2011;30:685-90.
23. Siegrist CA, Ambrosioni J, Bel M, et al. Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. Antivir Ther (Lond) 2012;17:893-903.
24. Torii Y, Kimura H, Ochi N, et al. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Vaccine 2011;29:4187-9.
25. Vazquez-Alvarez Mdel C, Medrano-Lopez C, Camino-Lopez M. H1N1 influenza vaccination and infection in pediatric heart transplants. J Heart Lung Transplant 2010;29:1318.
26. Hardelid P, Fleming DM, McMenamin J, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 2011;16:pii: 19763.
27. Sethi M, Pebody R. Pandemic H1N1 (swine) influenza vaccine uptake amongst patient groups in primary care in England 2009/10. Departement of Health-Health Protection Agency, 2010. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/215977/dh-121014.pdf (accessed 27 Feb 2015).
28. Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015;44:827-36.
29. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4-14.
30. Williams T, van Staa T, Puri S, et al. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012;3:89-99.
31. Health and Social Care Information Centre. Hospital Episode Statistics. http://www.hscic.gov.uk/hes (accessed 27 Feb 2015).
32. Sinha S, Peach G, Poloniecki JD, et al. Studies using English administrative data (Hospital Episode Statistics) to assess health-care outcomes-systematic review and recommendations for reporting. Eur J Public Health 2013;23:86-92.
33. Department of Health/Health Protection Agency. Pandemic H1N1 (swine) influenza vaccine uptake amongst patient groups in primary care in England 2009/10. http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/@dh/@en/@ps/documents/digitalasset/dh- 121014.pdf (accessed 27 Jan 2014).
34. Department of Health, United Kingdom. Pandemic H1N1 Vaccine Uptake Figures for England by SHA and PCT. http://webarchive. nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicy AndGuidance/DH-114203 (accessed 25 Mar 2015).
35. Weldeselassie YG, Whitaker HJ, Farrington CP. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect 2011;139:1805-17.
36. Whitaker HJ, Farrington CP, Spiessens B, et al. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006;25:1768-97.
37. Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 2009;10:3-16.
38. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995;51:228-35.
39. SAS Institute. Editorial Guidelines. http://www.sas.com/en-us/legal/editorial-guidelines.html (accessed 25 Mar 2015).
40. Andrews N, Stowe J, Al-Shahi Salman R, et al. Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine 2011;29:7878-82.
41. Arnheim-Dahlstrom L, Hallgren J, Weibull CE, et al. Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study. BMJ 2012;345:e7594.
42. Donegan K, Beau-Lejdstrom R, King B, et al. Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine 2013;31:4961-7.
43. Musonda P. The self-controlled case series method: performance and design in studies of vaccine safety [PhD thesis]. The Open University, 2006.
44. Romio S, Weibel D, Dieleman JP, et al. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PLoS ONE 2014;9:e82222.
45. Warren-Gash C, Hayward AC, Hemingway H, et al. Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis 2012;206:1652-9.
46. Crawford NW, Cheng A, Andrews N, et al. Guillain-Barre syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Med J Aust 2012;197:574-8.
47. Yung CF, Chan SP, Soh S, et al. Intussusception and monovalent rotavirus vaccination in Singapore: self-controlled case series and risk-benefit study. J Pediatr 2015;167:163-8.el.
48. Klein A, Lewis C, Madsen J. Organ Transplant. A Clinical Guide, 2011, Cambridge University Press, Section 2 (p63-69), Section 3 (p122-127), Section 4 (p173-181), Section 5 (p231-237) and Section 6 (p286-294).
49. European Society for Organ Transplantation. http://www.esot.org/ESOT/home (accessed 25 Mar 2015).
50. Läkemedelsverket Medical Products Agency. Final summary of adverse drug reaction reports in Sweden with Pandemrix through October 2009-mid April 2010. 2010. http://www.lakemedelsverket. se/upload/eng-mpa-se/Pandemrix%20ADRs%20in%20Sweden% 2015%20april%202010.pdf (accessed 27 Feb 2015).
51. Crockett F, Mal H, Amazzough K, et al. H1N1 (2009) influenza A infection in transplant recipient patients: a comparative study versus non-transplanted patients. Rev Pneumol Clin 2011;67:199-208.
52. Fox BD, Raviv Y, Rozengarten D, et al. Pandemic influenza (H1N1): impact on lung transplant recipients and candidates. J Heart Lung Transplant 2010;29:1034-8.
53. Freitas TV, Ono G, Correa L, et al. Clinical manifestations and evolution of infection by influenza A (H1N1) in kidney transplant recipients. J Bras Nefrol 2011;33:136-41.
54. Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010;10:521-6.
55. Low CY, Kee T, Chan KP, et al. Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore. Transplantation 2010;90:1016-21.
56. Vistoli F, Focosi D, De Donno M, et al. Pancreas rejection after pandemic influenza virus A(H1N1) vaccination or infection: a report of two cases. Transpl Int 2011;24:e28-9.
57. Stucchi RS, Boin IF, Angerami RN, et al. Correlations between A/H1N1 influenza and acute cellular rejection in liver transplantation patients. Transplant Proc 2010;42:4184-6.
58. Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis 2012;206:1250-9.
59. Pittet LF, Posfay-Barbe KM. Immunization in transplantation: review of the recent literature. Curr Opin Organ Transplant 2013;18:543-8.